Sage Journals: Discover world-class research

Abstract

To date, no data have been published on the use of OraQuick® ADVANCE Rapid HIV-1/2 Test (OraQuick) in the UK. We report preliminary findings of an ongoing evaluation of OraQuick in UK genitourinary (GU) medicine clinics. A total of 820 samples from patients in high-risk groups for HIV were tested with OraQuick and results were compared with standard HIV antibody testing. HIV prevalence (enzyme immunoassay [EIA]) was 5.73%, sensitivity of OraQuick was 93.64% (95% CI 82.46–98.66%), specificity 99.87% (99.28–100%), positive predictive value 97.78% (88.27–99.94%) and negative predictive value 99.61% (98.87–99.92%). This includes three false-negatives considered to be due to observer error and now rectified by further training. This has increased test sensitivity to 100%. Our observed test performance of OraQuick compares well with EIA and with other rapid tests. We believe that simple, non-invasive antibody detection tests such as OraQuick can increase HIV testing and diagnosis in UK GU medicine and community settings.

Keywords

point-of-care oral fluid HIV rapid tests

Get full access to this article

View all access options for this article.

References

Winter

, Sulaiman

, Hawkins

BASHH Clinical Governance Committee Guidance on the appropriate use of HIV point of care tests.

Int J STD AIDS 2006; 17: 802–5.

Dewsnap

, McOwan

A review of HIV point-of-care-tests.

Int J STD AIDS 2006; 17: 357–9.

San Antonio-Gaddy

, Richardson-Moore

, Burstein

GR.

Rapid HIV antibody testing in the New York State anonymous HIV counseling and testing program: experience from the field.

J Acquir Immune Defic Syndr 2006; 43: 446–50.

Giles

, Crocker

, Perry

, Parry

, Mortimer

PP.

Abbott Determine HIV-1/2 Simple/Rapid Test Device. Medical Devices Agency Evaluation Report, 1998. See [http://www.hpa-midas.org.uk/reports/reports_hiv.asp] (last checked 25 January 2008)

Delaney

, Branson

, Uniyal

Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies.

AIDS 2006; 20: 1655–60.

Pant Pai

, Joshi

, Dogra

Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India.

PLoS ONE 2007; 2: e367.

Gardner

, Altman

DG.

Calculating confidence intervals for proportions and their differences. In: Gardner

, Altman

, eds. Statistics with Confidence. London: BMJ Publishing Group, 1989: 28–33.

HIV 1/0/2 Enhanced 03162506 Rev A, 2005-2012. ADVIA Centaur Assay Manual. Tarrytown, NY: Bayer HealthCare LLC, 2005

Gallo

, George

, Fitchen

JH.

Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. Orasure Clinical Trials Group.

JAMA 1997; 277: 254–8.

10.

Rogstad

, Palfreeman

, Rooney

United Kingdom National Guidelines on HIV Testing 2006, Clinical Effectiveness Group British Association of Sexual Health and HIV. See [http://www.bashh.org/guidelines/2006/hiv_testing_june06.pdf] (last checked November 2007)

11.

The UK Collaborative Group for HIV and STI Surveillance.

Testing Times. HIV and Other Sexually Transmitted Infections in the United Kingdom. London: Health Protection Agency, Centre for Infections, 2007. See [http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/Default.htm] (last checked January 2008)

12.

Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS Epidemic Update, December 2007. See [http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2007/default.asp] (last checked January 2008)

13.

The National Strategy for Sexual Health and HIV, Department of Health, 21 July 2001. See [http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4058945.pdf] (last checked January 2008)

14.

World Health Organization. HIV Assays: Operational Characteristics (Phase I) Report 12. See [http://www.who.int/diagnostics_laboratory/publications] (last checked November 2007)

15.

Branson

BM.

Point-of-care rapid tests for HIV antibodies.

J Lab Med 2003; 27: 288–95.

16.

ECRI Institute.

Rapid HIV test kits (evaluation).

Health Devicesv 2006 May;35(5):157–77. See [http://www.ecri.org] (last checked March 2008)

17.

Rapid HIV testing: 2005 update (slide presentation online). See [www.cdc.gov/hiv/rapid_testing] (last checked March 2008)

18.

World Health Organization. HIV Assays: Operational Characteristics (Phase I) Report 14. See [http://www.who.int/diagnostics_laboratory/publications] (last checked March 2008)

19.

Smit

EJ.

Screening guidelines for sexually transmitted Infections: human immunodeficiency virus (HIV). In: Screening Guideline Steering Group Sexually Transmitted Infections: UK National Screening and Testing Guidelines. See [http://www.bashh.org/guidelines/2006/sti_screening_guidelines_v14_0806.pdf] (last checked February 2008)

An evaluation of the performance of OraQuick® ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London,UK

Abstract

Keywords

Get full access to this article

References